Verition Fund Management LLC Bellus Health Inc. Transaction History

Verition Fund Management LLC

  • $23.6 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$8.95 - $12.0 $4,108 - $5,508
459 Added 2.29%
20,542 $217,000
Q2 2022

Aug 15, 2022
BUY
$6.46 - $10.02 $536 - $831
83 Added 0.42%
20,083 $186,000
Q4 2021

Feb 14, 2022
BUY
$5.26 - $8.3 $52,600 - $83,000
10,000 Added 100.0%
20,000 $161,000
Q1 2020

May 15, 2020
BUY
$5.77 - $10.85 $57,699 - $108,500
10,000 New
10,000 $100,000

Others Institutions Holding BLU

# of Institutions
1
Shares Held
128K
Call Options Held
0
Put Options Held
0
View Full List

About BELLUS Health Inc.

BLU Quotes by TradingView
  • Ticker BLU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,793,000
  • Description
  • BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...
More about BLU
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email